清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With Pemphigus

医学 天疱疮 内科学 胃肠病学 美罗华 抗体 临床意义 随机对照试验 免疫学 淋巴瘤
作者
Alexandre Lemieux,Maud Maho-Vaillant,Marie-Laure Golinski,Vivien Hébert,Olivier Boyer,Sébastien Calbo,Sophie Candon,Pascal Joly
出处
期刊:JAMA Dermatology [American Medical Association]
卷期号:158 (8): 893-893 被引量:1
标识
DOI:10.1001/jamadermatol.2022.2149
摘要

The clinical relevance of antirituximab antibodies (ARAs) in patients with pemphigus who are treated with rituximab (RTX) is currently unknown.To determine the prevalence of ARAs in patients with pemphigus who are treated with RTX and their association with complete remission (CR) and relapse.This post hoc analysis of the Ritux3 trial was conducted from January 2010 to December 2015 in 25 dermatology departments in France and included 42 patients with moderate-to-severe pemphigus who were randomized to receive treatment with RTX. Five additional patients were recruited for an ancillary study. The proportions of patients who achieved CR or relapsed after an initial treatment cycle of RTX were compared depending on whether patients had ARAs.Patients were treated with 1000 mg of RTX on days 1 and 15 and 2 maintenance infusions of 500 mg at months 12 and 18.Rates of relapse and sustained CR at month 36. Levels of ARAs, antidesmoglein 1/3 antibodies, RTX serum concentrations, and peripheral blood CD19+ B-cell frequency were measured.Of 42 participants with vs without ARAs, the mean (SD) age was 55 (17) years and 56 (17) years, respectively; 25 (59.5%) were women. Antirituximab antibodies were detected in the serum samples of 13 of 42 patients (31%) during the first year. Nine patients who experienced relapse before month 12 were excluded because they received additional infusions and could not be further analyzed. Among the 33 remaining patients, 2 patients (6.1%) experienced relapse after month 12, and 31 (95.9%) maintained a sustained CR until month 36. The rate of sustained CR was not different whether patients had ARAs (11 of 13 [85%]) or not (20 of 20 [100%]) (P = .15). Both groups (ARA+ vs ARA-) also had similar CD19+ B-cell depletion and RTX levels, but patients with ARAs had higher anti-desmoglein 3 antibody (DSG3 Abs) levels compared with those without ARAs (mean [SD], 30.1 [50.9] AU/mL vs 4.0 [4.3] AU/mL; P = .03). The 2 patients with ARAs who experienced relapse after month 12 had an undetectable RTX level, incomplete B-cell depletion, and higher anti-DSG3 Abs level than the 11 patients who maintained a sustained CR with ARAs (RTX mean [SD] concentration, 0 ug/mL vs 12.5 [2.2] ug/mL; P = .03; incomplete B-cell depletion, 2 of 2 vs 4 of 11; P = .19; mean [SD] anti-DSG3 Abs levels, 103.5 [61.5] AU/mL vs 19.5 [11.0] AU/mL; P = .001) or patients without ARAs (mean [SD] RTX concentration, 0 ug/mL vs 13.5 [1.8] ug/mL; P = .02; incomplete B-cell depletion, 2 of 2 vs 5 of 20; P = .09; mean [SD] anti-DSG3 Abs level, 103.5 [61.5] AU/mL vs 4.0 [1.0] AU/mL; P < .001).The results of this cohort study suggest that ARAs are frequently detected in patients with pemphigus who are treated with RTX and generally are not associated with patient outcomes. Only a few patients with the combination of ARAs, low RTX concentration, incomplete B-cell depletion, and persistent serum anti-DSG3 Abs seem at high risk of relapse.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HEIKU完成签到 ,获得积分0
46秒前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
ziyewutong完成签到,获得积分10
1分钟前
1分钟前
糊涂的青烟完成签到 ,获得积分10
2分钟前
2分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
圈圈完成签到 ,获得积分10
3分钟前
3分钟前
hx发布了新的文献求助10
3分钟前
圈圈关注了科研通微信公众号
3分钟前
mf2002mf完成签到 ,获得积分10
3分钟前
4分钟前
文与武完成签到 ,获得积分10
4分钟前
csatsd发布了新的文献求助10
4分钟前
4分钟前
hx完成签到,获得积分20
4分钟前
4分钟前
科研通AI2S应助科研通管家采纳,获得10
5分钟前
充电宝应助科研通管家采纳,获得10
5分钟前
5分钟前
6分钟前
牛安荷发布了新的文献求助10
6分钟前
6分钟前
DJ_Tokyo完成签到,获得积分10
6分钟前
dream完成签到 ,获得积分10
7分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
7分钟前
科研螺丝完成签到 ,获得积分10
8分钟前
嗯呐发布了新的文献求助10
8分钟前
三日发布了新的文献求助10
8分钟前
三日完成签到,获得积分10
8分钟前
牛安荷完成签到,获得积分10
8分钟前
9分钟前
英姑应助嗯呐采纳,获得10
10分钟前
Tumumu完成签到,获得积分10
10分钟前
10分钟前
嗯呐发布了新的文献求助10
11分钟前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger Heßler, Claudia, Rud 1000
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 1000
Natural History of Mantodea 螳螂的自然史 1000
A Photographic Guide to Mantis of China 常见螳螂野外识别手册 800
How Maoism Was Made: Reconstructing China, 1949-1965 800
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 量子力学 冶金 电极
热门帖子
关注 科研通微信公众号,转发送积分 3316984
求助须知:如何正确求助?哪些是违规求助? 2948754
关于积分的说明 8541962
捐赠科研通 2624676
什么是DOI,文献DOI怎么找? 1436378
科研通“疑难数据库(出版商)”最低求助积分说明 665891
邀请新用户注册赠送积分活动 651810